CRP and coronary artery disorder: There appear even to be advantages with small to moderate reductions in established markers of blood lipids (LDL-C, non-HDL-C) that are in line with approved health claims for cholesterol and coronary heart disease risk reduction, as well as small to moderate reductions in blood pressure and inflammation (CRP).